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Abstract Swelling of non-respiring rat liver mitochondria
suspended in isotonic potassium acetate at pH 6.5^7.4 in the
presence of valinomycin was promoted by long-chain fatty acids,
such as myristate, indicating a protonophoric mechanism. This
swelling was partly inhibited by inhibitors or substrates of
mitochondrial anion carriers. The results show that the fatty acid
cycling mechanism responsible for uncoupling of oxidative
phosphorylation can also operate in the direction opposite to
that originally proposed [Skulachev, V.P. (1991) FEBS Lett.
294, 158^162], i.e. the inwardly directed transfer of the fatty acid
anion accompanied by outwardly directed free passage of
undissociated fatty acid. They also extend the list of mitochon-
drial anion carriers, that are involved in this process, over the
mono- and tricarboxylate transporters. At pH 8, myristate, but
not the synthetic protonophore, p-trifluoromethoxycarbonyl-
cyanide phenylhydrazone, induced mitochondrial swelling in both
potassium acetate and KCl media, that did not require the
presence of valinomycin. This indicates that, at alkaline pH,
myristate facilitates permeation of the inner mitochondrial
membrane to monovalent cations and, possibly, activates the
inner membrane anion channel.
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1. Introduction
Non-esteri¢ed (‘free’) long-chain fatty acids (FFA) are
known since about four decades as uncouplers of oxidative
phosphorylation, but their protonophoric e¡ect has not been
completely resolved yet (for reviews see [1,2]). The protono-
phoric activity of FFA [3,4] is limited by a low £ip-£op ability
of FFA anions in arti¢cial [5] and mitochondrial membranes
[6]. It has been ¢rst reported by the Skulachev’s group [3,7]
that carboxyatractyloside, a speci¢c inhibitor of the ADP/
ATP carrier, partially reversed the protonophoric activity of
FFA in mitochondria. Mainly on this basis Skulachev [8]
postulated that the undissociated FFA permeate from the ex-
ternal side of the inner membrane to the matrix side and that
the reverse transport of FFA anion is mediated by the ADP/
ATP carrier (fatty acid cycling model) [8]. Later on, this view
was extended by involving other anion carrier proteins of the
inner membrane, such as the aspartate/glutamate carrier [9]
and the dicarboxylate carrier [10] in the back-transport of
FFA anions (for review see also [11]).
However, especially in liver mitochondria, the protono-
phoric activity of FFA can be attributed only partly to these
anion carriers [12,13]. For example, the ADP/ATP carrier and
the aspartate/glutamate carrier account for only about 25% of
the protonophoric activity of the branched chain phytanic
acid (3,7,11,15-tetramethylhexadecanoic acid) [13]. Therefore,
it seems likely that other up to now unrecognized inner mem-
brane proteins may contribute to the FFA-mediated trans-
membrane proton transfer. In the present report we applied
the swelling approach to look for the involvement of various
anion carriers in the protonophoric activity of FFA.
Non-respiring rat liver mitochondria incubated in bu¡ered
isotonic potassium acetate in the presence of valinomycin do
not swell, because acetate can cross the membrane only as
undissociated acetic acid, and the transmembrane passage of
potassium in form of the K-valinomycin complex generates a
charge imbalance, preventing further permeation of K. In-
tramitochondrial accumulation of potassium acetate becomes
only possible if H can be exported from the inner compart-
ment, thus enabling the in£ow of K. This process can be
mediated for example by synthetic protonophores [14]. Such
swelling can be, therefore, used to check protonophoric ability
of various compounds, among them fatty acids. In that case
FFA would export protons from mitochondria by entering
the inner compartment in the anionic form and £ip-£opping
in the reverse direction as undissociated acid (Fig. 1). The
‘swelling system’ has the advantage over the ‘respiratory sys-
tem’ in searching for the mechanisms of protonophoric action
of FFA because it eliminates the e¡ects of inhibitors of anion
carriers on the mitochondrial respiratory chain and primary
dehydrogenases. In addition, in the ‘swelling system’, fatty
acid anions are expected to be transported by the anion car-
riers from the external side of the membrane to its internal
side, i.e. in the direction opposite to that postulated for FFA-
induced uncoupling in energized mitochondria [8,11].
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 3 7 6 - 4
*Corresponding author. Fax: (49)-391-67 13050.
E-mail: peter.schoenfeld@medizin.uni-magdeburg.de
Abbreviations: BCECF, 2P,7P-bis-(2-carboxyethyl)-5(6)-carboxy£uo-
rescein; CAT, carboxyatractyloside; DCCD, dicyclohexylcarbo-
diimide; FFA, non-esteri¢ed long-chain fatty acids; FCCP, carbon-
yl-cyanide p-tri£uoromethoxyphenylhydrazone; IMAC, inner mem-
brane anion carrier; Val, valinomycin
FEBS 23514 30-3-00
FEBS 23514FEBS Letters 471 (2000) 108^112
2. Materials and methods
2.1. Mitochondria
Liver mitochondria were prepared from adult female Wistar rats
(average weight 150^180 g) according to our standard protocol [4].
Protein content in the mitochondrial stock suspension was determined
by a modi¢ed biuret method.
2.2. Swelling measurement
Swelling of deenergized rat liver mitochondria was recorded as the
decrease of turbidity of the mitochondrial suspension. In short, an
aliquot of mitochondria (1 mg mitochondrial protein) was added to
1 ml of the ‘swelling medium’ consisting of 120 mM K-acetate, 10
mM Tris^HCl, 0.5 mM EGTA, 2 WM rotenone and 0.5 WM valino-
mycin, adjusted to the required pH. It was found in preliminary ex-
periments (not shown) that FFA can initiate the permeability transi-
tion even in the absence of externally added Ca2 and in phosphate-
free medium. Therefore, in order to eliminate possible contribution of
the permeability transition [15] to mitochondrial swelling, the potas-
sium acetate medium was additionally supplemented with 1 WM cyclo-
sporin A, a potent blocker of the permeability transition pore [16].
Mitochondria were preincubated for 2 min in this swelling medium
without or with the inhibitors to be examined and then the swelling
was initiated by the addition of myristate or palmitate in form of 10
mM sodium salts in water or ethanol. Swelling was measured with a
Cary 3E UV-visible spectrophotometer at 22‡C and was quanti¢ed by
determination of the initial rate of the decrease of light absorbance at
540 nm using the photometer software.
2.3. Mitochondrial membrane potential, respiration and other
procedures
Oxygen consumption by mitochondria was measured polarograph-
ically using a Clark-type electrode in a chamber thermostated at 25‡C.
The ‘respiration medium’ was composed of 110 mM mannitol, 60 mM
KCl, 60 mM Tris^HCl, 10 mM K2HPO4, 0.5 mM Na2EDTA and
5 mM glutamate plus 5 mM malate as respiratory substrates (pH 7.4).
The mitochondrial membrane potential (vi) was measured at 25‡C
in a medium containing 120 mM KCl, 10 mM Tris^HCl and 0.5 mM
EGTA using the TPP-selective electrode [17] or by safranin O £uo-
rescence [18]. pH gradient between mitochondrial inner compartment
and the external medium (vpH) was measured using the £uorescent
pH probe BCECF [19].
Rupture of the mitochondrial inner membrane by lytic activity of
the applied FFA was assessed by measuring the release of the matrix
enzyme malate dehydrogenase that was determined according to [20].
2.4. Chemicals
Myristic acid (C14:0), FCCP, n-butylmalonate, phenylsuccinate,
1,2,3-benzene tricarboxylate, carboxyatractyloside, glutamate, malate,
K-cyano-3-hydroxycinnamate, dicyclohexylcarbodiimide, safranin O
and cyclosporin A were from Sigma (St. Louis, MO, USA). Acetox-
ymethyl ester of BCECF was from Molecular Probes (Eugen, OR,
USA).
3. Results
Rat liver mitochondria swelled only slightly when sus-
pended in K-acetate medium bu¡ered at pH 7.4. Neither va-
linomycin, FCCP, nor myristate added alone accelerated the
swelling (Fig. 2, traces A, B and C). As it is well known [14],
valinomycin and the protonophore (FCCP in this case), when
present together, produced a rapid swelling (Fig. 2, trace D).
Similarly, the swelling was accelerated by myristate, or palmi-
tate or oleate (not shown), added in the presence of valino-
mycin (Fig. 2, trace E). When the rate of initial swelling and
the stimulation of resting state respiration were plotted
against the amount of myristate added, a similar dependence
was found (Fig. 3). This result strengthens the view that the
swelling depends on the protonophoric action of myristate, as
does the uncoupling of respiration.
Mitochondrial swelling in K-acetate medium was partly in-
hibited by well known inhibitors or substrates of various mi-
tochondrial anion carrier proteins (Fig. 4): CAT (inhibitor of
the ADP/ATP carrier), glutamate (substrate of the glutamate/
aspartate carrier), K-cyano-3-hydroxycinnamate (inhibitor of
the monocarboxylate carrier), phenylsuccinate and n-butyl-
malonate (inhibitors of the dicarboxylate carrier) and 1,2,3-
benzenetricarboxylate (inhibitor of the tricarboxylate carrier).
Measurements of the membrane potential (v8) in mitochon-
dria energized with N,N,NP,NP-tetramethyl-p-phenylenedi-
amine (plus ascorbate) revealed that these inhibitors (with
the exception of K-cyano-3-hydroxycinnamate) as well as cit-
rate (substrate of the tricarboxylate carrier) partly restored
v8 decreased by the addition of myristate (not shown). It
has to be noted that in this system energization of mitochon-
dria was independent of NAD-linked substrates (for experi-
mental details see [10]).
In non-respiring mitochondria suspended in the K-acetate
medium addition of valinomycin did not elicit a potassium
di¡usion membrane. This has to be expected since the external
concentration of potassium ions was approximately equal to
the internal one estimated to be about 120 mM [18]. In con-
trast, mitochondria suspended in potassium acetate exhibited
a pH gradient, acidic inside, due to the permeability of the
Fig. 1. Two experimental approaches to study the protonophoric
mechanism of fatty acids in mitochondria. In mitochondria ener-
gized by operation of the respiratory chain (‘respiratory system’),
the protonophoric function of FFA results in a decrease of the
membrane potential and, as consequence, an increase of the non-
phosphorylating respiration. In the ‘swelling system’, non-energized
mitochondria are suspended in isotonic potassium acetate. Because
the inner mitochondrial membrane is permeable to undissociated
acetic acid but not to the acetate anion, such mitochondria do not
accumulate potassium acetate, even in the presence of K iono-
phore, valinomycin, unless the protonophoric activity of FFA ena-
bles the export of protons. This is followed by osmotic swelling and
manifested by a decrease of light scattering. In both systems the
transmembrane proton passage is controlled by FFA anion capabil-
ity to cross the inner membrane: in the ‘respiratory system’ from
the inner side of the membrane to its external side, in the ‘swelling
system’ in the reverse direction. For further explanation see text. In-
dications and abbreviations: RCOOH and RCOO3, long-chain fatty
acid and its anion, respectively; KAc, HAc and Ac3, potassium
acetate, acetic acid and acetate anion, respectively; ACs, mitochon-
drial anion carriers; RC, respiratory chain.
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inner membrane to undissociated acetic acid but not to ace-
tate anion. This pH gradient amounted to about 0.3 pH unit
and slowly decreased to 0.1 pH unit after addition of valino-
mycin (not shown). Thus, in non-respiring mitochondria sus-
Fig. 2. Myristate- and FCCP-supported swelling of rat liver mito-
chondria in potassium acetate medium. Experimental conditions
were as in Section 2. The experiments were started by the addition
of mitochondria (1 mg protein; not shown) to the ‘swelling medium’
with valinomycin (A, D, E) or without valinomycin (B, C). Final
concentrations of the additions (arrows) were: 2 WM FCCP (B, D),
80 WM myristate (C, E).
Fig. 3. Dependence of mitochondrial swelling and oxygen uptake on
myristate concentration. Swelling was measured as in Fig. 2. The
respiration was measured by incubation of mitochondria (1 mg pro-
tein/ml) in the ‘respiration medium’. The non-phosphorylating respi-
ration of mitochondria was titrated with FCCP to the maximum.
Then, the respiration and swelling were stimulated by various con-
centrations of myristate and were expressed in percentage of that
stimulated by FCCP. The data are mean values þ S.D. for three mi-
tochondrial preparations, corrected for basic swelling or respiration
(without fatty acid), respectively.
Fig. 4. The e¡ect substrates or inhibitors of mitochondrial anion
carriers on the myristate-induced swelling. Mitochondria were prein-
cubated in the complete ‘swelling medium’ (pH 7.4) with the e¡ec-
tors of respective anion carriers: 5 WM CAT, 10 mM glutamate,
100 WM K-cyano-3-hydroxycinnamate (K-CC), 10 mM phenylsucci-
nate, 10 mM n-butylmalonate or 10 mM 1,2,3-benzenetricarboxylate
(1,2,3-BTC). The normalized swelling rate (SR) was calculated from
the rate of the decrease in light scattering before (DLSE) and after
(DLSEMyr) addition of 80 nmol myristate/mg mitochondrial protein:
SR = 100U(DLSEMyr3DLS
E)/(DLSMyr3DLS), where DLSMyr and
DLS are rates of the decrease of light scattering with and without
myristate, respectively, without the e¡ector. The data shown
(means þ S.D.) were calculated from experiments performed with
¢ve to seven mitochondrial preparations.
Fig. 5. E¡ect of pH on myristate- or FCCP-induced mitochondrial
swelling. Mitochondria were incubated without or with 0.5 WM vali-
nomycin in the ‘swelling medium’ adjusted to various pH values. In-
itial rates of swelling stimulated by addition of 80 nmol myristate/
mg mitochondrial protein or by 2 WM FCCP were plotted against
pH of the medium. The data are mean values þ S.D. for six mito-
chondrial preparations.
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pended in isotonic K-acetate the driving force for the circu-
lation of fatty acid was vpH rather than vi.
The characteristics of mitochondrial swelling changed dras-
tically with increasing pH of the medium. As shown in Fig. 5,
the initial rate of swelling with myristate alone, myristate plus
valinomycin, and FCCP plus valinomycin was strongly in-
creased when pH was increased from 7.4 to 8.0. The swelling
in the presence of FCCP or valinomycin alone was very low
and was independent of pH in the range of 6.5^8.0.
As expected, the mitochondria did not swell at pH 7.4 when
suspended in KCl medium in the presence of myristate (Fig. 6,
trace A) or valinomycin (not shown, see [21]). However at pH
8, in contrast to what had been observed in the K-acetate
medium (see Fig. 2), myristate alone initiated swelling in the
KCl medium (Fig. 6, trace C). At that alkaline pH, the swell-
ing was only slightly induced by valinomycin alone (Fig. 5,
trace D; see also [21]). Myristate-induced swelling was inhib-
ited by dicyclocarbodiimide (Fig. 5, traces E). FCCP did not
induce mitochondrial swelling at pH 8.0 (Fig. 6, trace B).
Leakage of malate dehydrogenase from mitochondria to the
external medium (K-acetate or KCl medium) amounted to
2.5^3.5% at pH range of 7.4^8.0 and increased to only 5.5%
at pH 8.0 in the presence of myristate. This indicates that the
observed increase of the rate of light scattering decrease at
more alkaline pH could not be due to an increase in the lysis
of mitochondria but points to a real increase of swelling at pH
8.0.
4. Discussion
In the present study the protonophoric e¡ect of FFA was
investigated using the protonophore-mediated swelling of
non-respiring mitochondria suspended in K-acetate medium
supplemented with valinomycin [14], i.e. under conditions
when FFA mediate a net transfer of protons from the inside
to the outside of the inner membrane, that is, in the opposite
direction than during FFA-induced uncoupling [8]. These re-
sults clearly show the fatty acid cycling mechanism can oper-
ate in both directions. In addition, they also indicate that the
FFA-mediated protonophoric mechanism can function in
non-energized mitochondria, when the driving force for cy-
cling of the protonated form of fatty acid versus its anionic
form is greatly reduced. Moreover, they provide a ¢nal sup-
port to the concept that the uncoupling e¡ect of FFA is due
to the protonophoric mechanism rather than to an interaction
with the respiratory chain or the energy-generating machinery
(for discussion of this point see [1]).
The present study also extends the list of mitochondrial
anion carriers, that can be involved in the fatty acid anion
transfer, over two more members of this carrier protein fam-
ily: the tricarboxylate carrier and, most likely, the monocar-
boxylate carrier. It seems, however, likely that the mitochon-
drial anion carriers can transport fatty acid anions in both
directions with di¡erent rates. This is indicated by the obser-
vation that blocking of a particular carrier may exert di¡erent
e¡ects on the recoupling (vi increase) and the FFA-mediated
swelling. For example, we were unable to see any e¡ect of
K-cyano-3-hydroxycinnamate on the myristate-induced de-
crease of vi, whereas the swelling was decreased by some
30% (Fig. 4). Similarly, blocking of the glutamate carrier
had a smaller e¡ect on the swelling than blocking of the
dicarboxylate carrier (Fig. 4). In contrast, blocking of the
glutamate carrier had a higher recoupling e¡ect than blocking
of the dicarboxylate carrier [10].
Furthermore, we report ^ to our knowledge for the ¢rst
time ^ on a FFA-induced very pronounced mitochondrial
swelling at alkaline pH in K-acetate, which is not attributable
to protonophoric action (Fig. 5). This swelling also occurred
in KCl medium (Fig. 6) and was independent of valinomycin,
therefore pointing to a di¡erent mechanism, namely permea-
bilization of the mitochondrial inner membrane to both K
and Cl3. In the absence of FFA, an increase of mitochondrial
permeability to chloride as well as an increase in swelling of
rat liver mitochondria in KCl medium (plus valinomycin) at
alkaline pH have been previously described [21,22]. Both phe-
nomena might be explained by operation of the inner mem-
brane anion channel (IMAC) [23]. This suggests that myris-
tate can act as activator of IMAC at alkaline pH and, in
addition, increases permeability of the inner membrane to
K. The latter phenomenon could be due to the capability
of FFA to transport monovalent cations as fatty acid com-
plexes or soap (‘valinomycin-like e¡ect’) [24^26].
In liver mitochondria, IMAC is activated by increasing the
pH or by lowering matrix Mg2 [27]. Thus, it could be that
FFA extract Mg2 from the matrix by formation of a stable
fatty acid anion^Mg2 complex inside mitochondria and its
Fig. 6. Myristate-induced swelling of rat liver mitochondria in the
KCl medium. Mitochondria (1 mg protein/ml) were incubated in the
K-chloride medium: 120 mM KCl, 10 mM Tris^HCl, 0.5 mM
EGTA, 1 WM rotenone, 1 WM cyclosporin A; pH was adjusted to
7.4 (A) or 8.0 (B^E). Final concentrations of the additions (arrows)
were: 80 WM myristate (A, C, E), 2 WM FCCP (B) and 0.5 WM vali-
nomycin (D). In one experiment mitochondria were preincubated
for 2 min with 0.1 WM DCCD (E).
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subsequent outward transport [28]. In addition, the ¢nding
that dicyclohexylcarbodiimide, a known inhibitor of IMAC
[27], inhibits myristate-supported swelling, further strengthens
our proposal of IMAC activation by fatty acids at alkaline
pH.
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